MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fpubh.2026.1887503

Медицинская библиотека · Frontiers in public health · 2026

Development and validation of a nomogram for identifying prevalent sarcopenia in Chinese patients with Cardiovascular-Kidney-Metabolic Syndrome.

Yang Chengjun, He Qiaohui, Liang Haiwen, Song Junru, Wen Zehuai, Qiu Xingying, Chen Xiankun, Cai Huayang

СтатьяВалидационное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Sarcopenia is recognized as a significant comorbidity in patients with Cardiovascular-Kidney-Metabolic (CKM) Syndrome, yet validated prediction models for this population remain lacking. This study aimed to develop and validate a nomogram for predicting sarcopenia risk in Chinese patients with CKM syndrome.

METHODS

Data were derived from the China Health and Retirement Longitudinal Study (CHARLS) and an independent hospital dataset. The CHARLS 2015 dataset was split into a training set and an internal validation set; the CHARLS 2011 dataset served as the external validation set; and inpatients from Guangdong Provincial Hospital of Chinese Medicine constituted the hospital validation set. Sarcopenia was diagnosed according to the 2025 Asian Working Group for Sarcopenia criteria. Least absolute shrinkage and selection operator (LASSO) regression combined with multivariable logistic regression was used for predictor selection and model development. Model performance was evaluated by discrimination, calibration, and decision curve analysis (DCA).

RESULTS

Nine predictors were identified: age, smoking status, high-density lipoprotein cholesterol, triglycerides, uric acid, C-reactive protein, hemoglobin, chronic obstructive pulmonary disease, and chronic liver disease. The model achieved area under the curve values of 0.817, 0.808, 0.800, and 0.834 in the training, internal validation, external validation, and hospital validation sets, respectively. Calibration was satisfactory in development cohorts (p > 0.05), with some calibration drift in external populations. DCA confirmed clinical utility across all datasets.

CONCLUSION

The developed nomogram incorporating nine accessible predictors demonstrated robust discrimination and clinical applicability for sarcopenia risk assessment in Chinese CKM patients, supporting its use in early screening and individualized intervention.

Для цитирования: Yang Chengjun, He Qiaohui, Liang Haiwen, Song Junru, Wen Zehuai, Qiu Xingying, Chen Xiankun, Cai Huayang. Development and validation of a nomogram for identifying prevalent sarcopenia in Chinese patients with Cardiovascular-Kidney-Metabolic Syndrome.. Frontiers in public health. 2026. DOI: 10.3389/fpubh.2026.1887503.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.